Medscape Medical NewsAll articles

DEEPECHO

DeepEcho • Radiology • 05/23/2025

510(k)IEC 62304 Class B§524B Cyber Device
FDA Summary PDF

Device Purpose

DEEPECHO is a cloud-based machine learning software designed to assist healthcare professionals in analyzing fetal ultrasound images for biometric measurements and anatomical view identification. It utilizes advanced machine learning techniques validated through non-clinical testing against expert annotations, demonstrating high accuracy and robust performance across diverse patient and equipment parameters, thus serving as a safe and effective concurrent reading and measuring aid.

Summary

Deep Echo has developed DEEPECHO, a cloud-based software designed to assist qualified healthcare professionals in analyzing fetal ultrasound images and clips. This software utilizes machine learning techniques to detect standard biometry views, such as cephalic, abdominal, and femoral, and then helps compute various fetal biometric parameters including head circumference, abdominal circumference, femur length, and bi-parietal diameter, as well as estimated fetal weight and gestational age. It is intended for use by trained professionals as a concurrent reading and measuring aid for pregnant patients aged 18 and older, between 14 and 41 weeks of pregnancy, supporting both post-exam image file analysis and real-time image streaming.To evaluate its performance, DEEPECHO underwent comprehensive non-clinical testing, comparing its analysis to ground truth annotations by expert sonographers across a diverse dataset of ultrasound studies. The primary endpoints included the accuracy of continuous measurements for key fetal parameters and the sensitivity and specificity of anatomical view identification. The results demonstrated high accuracy for the biometric measurements and robust sensitivity and specificity in detecting the required views. Subgroup analyses confirmed consistent performance across different maternal ages, gestational ages, BMI categories, and ultrasound system manufacturers, supporting the conclusion that DEEPECHO is a safe and effective tool.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Deep EchoDEEPECHOFetal ultrasoundMachine learningBiometryGestational ageEstimated fetal weightImage analysisAccuracySonographers

Device Metadata

Submission Number
K242594
Company
DeepEcho
Panel
Radiology
Product Code
N/A
Data Type
N/A
Clinical Function
N/A
AI Function
N/A
AI Subclass
N/A

Relevant Clinical Questions

  • Q1. How does DEEPECHO's performance compare to manual measurements by multiple sonographers in a diverse clinical setting, beyond the non-clinical testing environment?; What are the specific machine learning models and algorithms employed by DEEPECHO for view detection and biometric parameter computation, and how are they robust against variations in image quality or atypical fetal presentations?; Are there any known limitations or specific scenarios (e.g., multifetal pregnancies, certain anomalies) where DEEPECHO's accuracy might be compromised, and how are these addressed?; What kind of training or certification is required for healthcare professionals to effectively use and interpret DEEPECHO's output, and how does the software integrate into existing clinical workflows?; What is the long-term data collection strategy for DEEPECHO, and how will continuous learning or updates ensure sustained accuracy and adaptation to evolving clinical standards or new ultrasound technologies?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Qualifies as a cyber device under §524B (post-Dec 2023, networked)

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score35/100
SBOM Evidence⚠ Not in summary - likely in full submission per §524B
Cyber Risk Assessment✓ Detected in Summary
Postmarket Plan⚠ Not in summary - likely in full submission per §524B
§524B ApplicableYes

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(machine learning, algorithm, dataset, ground truth, annotation)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(cloud)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials(environment)
✓ Detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM, OBOM detected in AI-generated device summary.

• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
DEEPECHO - DeepEcho | ESL FDA AI Device Intelligence